Omron Visceral Fat Level: Scale, Ranges & Tips

Omron visceral fat level readings offer a practical way to monitor one of the most clinically significant aspects of body composition at home. Visceral fat, stored deep around the abdominal organs, carries greater health risks than surface fat and is linked to type 2 diabetes, cardiovascular disease and metabolic liver conditions. Omron body composition monitors use bioelectrical impedance analysis to estimate visceral fat on a proprietary scale, giving users a consistent reference point for tracking changes over time. This article explains how the scale works, what the numbers mean, how accurate the readings are, and what you can do if your level is high.

What is visceral fat and why does it matter for your health?

Visceral fat surrounds the abdominal organs and is metabolically active, raising the risk of type 2 diabetes, cardiovascular disease and metabolic liver disease. NICE recommends waist-to-height ratio alongside BMI to assess cardiometabolic risk.

Visceral fat is the fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it carries greater health risks than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at your waist, visceral fat is metabolically active, releasing hormones and inflammatory chemicals that can disrupt normal organ function over time.

Excess visceral fat is strongly associated with an increased risk of several serious conditions, including:

• Type 2 diabetes, through its effect on insulin resistance

• Cardiovascular disease, including high blood pressure and raised cholesterol

• Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as non-alcoholic fatty liver disease (NAFLD)

• Certain cancers, including colorectal cancer

NICE guidance on obesity assessment in adults recommends using waist-to-height ratio alongside BMI, recognising that two people with identical BMI values can carry very different amounts of visceral fat.^[1][2] A waist-to-height ratio of 0.5 or above is generally considered to indicate elevated cardiometabolic risk. Waist circumference is also used as a practical proxy measure in NHS settings.

Visceral fat accumulates for a variety of reasons, including a sedentary lifestyle, a diet high in refined carbohydrates and saturated fats, poor sleep, chronic stress and hormonal changes associated with ageing. Fat distribution tends to shift towards the abdomen after the menopause, which is a recognised pattern in clinical practice.^[5][6] Understanding your visceral fat level is therefore a meaningful step in assessing your overall cardiometabolic health, rather than relying on weight or BMI alone.

How does an Omron device measure your visceral fat level?

Omron monitors use bioelectrical impedance analysis, passing a low-level electrical current through the body and applying proprietary algorithms to estimate visceral fat as a number on their own scale. Readings should be taken consistently, ideally in the morning before eating or exercising.

Omron body composition monitors estimate visceral fat using a technique called bioelectrical impedance analysis (BIA), in which a low-level, imperceptible electrical current is passed through the body to measure resistance to that current. Because fat, muscle and water conduct electricity differently, the device uses the resulting data alongside personal inputs such as age, height, sex and activity level to calculate body composition, including an estimate of visceral fat.

Some Omron models, such as those in the HBF series (for example the BF511 and HBF-702T), use multiple electrodes in both the foot plates and handheld grips to send currents through the upper and lower body simultaneously. This whole-body approach captures a broader picture of fat distribution than devices that measure only from the feet upward, though it remains an estimate rather than a direct measurement.

The device does not directly visualise fat around the organs. Instead, it applies proprietary algorithms developed from population studies to translate impedance measurements into an estimated visceral fat level, expressed as a number on Omron's own scale. The reading is therefore an estimate, and its accuracy can be influenced by factors such as hydration status, recent exercise, food intake and skin temperature.

For consistent results, Omron recommends measuring at the same time of day, ideally in the morning before eating or exercising. Readings taken under varying conditions may differ meaningfully, so trends over time are more informative than any single measurement. You should always use the same device for comparisons, as readings are not directly comparable between different devices or brands.

Important safety note: BIA devices, including Omron monitors, should not be used by people who have an implanted cardiac device such as a pacemaker or implantable cardioverter-defibrillator (ICD), as the electrical current may interfere with the device.^[8][9] People who are pregnant should also avoid using BIA monitors, as the safety of the electrical current in pregnancy has not been established. If you are unsure whether it is safe for you to use a BIA device, check your device manual and consult your GP or specialist before use.

What is a healthy visceral fat level on an Omron scale?

On Omron's scale, 1 to 9 is healthy, 10 to 14 is high, and 15 or above is very high. These thresholds are specific to Omron's algorithm and do not correspond to clinical measurements used in NHS settings.

On Omron's proprietary visceral fat scale, as defined in Omron device user manuals (such as those for the BF511 and HBF-702T), a reading of 1 to 9 is considered a healthy range, a reading of 10 to 14 is classified as high, and a reading of 15 or above is classified as very high. These thresholds are specific to Omron's algorithm and scale and are not directly equivalent to clinical measurements used in NHS or research settings.

It is important to understand that Omron's scale is a relative indicator rather than an absolute clinical measure. The numbers do not correspond to a specific volume of visceral fat in litres or kilograms. They are designed to give users a consistent, comparable reference point when tracking changes over time using the same device.

Age and sex influence what is considered a typical visceral fat level. Visceral fat tends to increase with age, and men generally carry more visceral fat than women of the same BMI, though this difference narrows after the menopause.^[5][6] The category thresholds displayed on Omron devices apply uniformly across adults; users should refer to their specific device manual to confirm how their model applies these categories.

If your Omron reading falls in the high or very high category, this is a prompt to discuss your results with your GP rather than a diagnosis in itself. Your GP can assess your overall cardiometabolic risk using a combination of measures, including waist-to-height ratio, waist circumference, blood pressure, fasting glucose or HbA1c, and lipid profile, using tools such as QRISK in line with NICE guidance on cardiovascular risk assessment. A single elevated reading should be interpreted alongside these broader clinical factors.

How accurate are Omron visceral fat readings compared to NHS tests?

Omron BIA readings correlate reasonably with visceral fat at population level but are less accurate than CT, MRI or DXA scanning, which are the clinical gold standards. In NHS practice, waist-to-height ratio and waist circumference are the recommended proxy measures.

Omron visceral fat readings provide a useful estimate but are not as accurate as the imaging methods used in clinical and research settings, such as computed tomography (CT) or magnetic resonance imaging (MRI), which are considered the gold standard for quantifying visceral fat.^[14] Dual-energy X-ray absorptiometry (DXA) scanning is also used in some NHS and research contexts and offers greater precision than BIA.

Studies comparing BIA-based devices with imaging methods have generally found that BIA correlates reasonably well with visceral fat at a population level, meaning the technology can identify people with higher versus lower visceral fat with reasonable reliability. However, individual-level accuracy is more variable, and BIA devices can over- or underestimate visceral fat in certain groups, including older adults, people with very high or very low body fat percentages, and those with conditions affecting fluid distribution such as kidney disease or heart failure.

In routine NHS practice, CT, MRI and DXA are not used to screen for visceral fat in the general population because of cost, radiation exposure (in the case of CT) and limited availability. Instead, clinicians use proxy measures such as waist-to-height ratio and waist circumference, which are practical, validated and recommended in NICE and NHS guidance on obesity and cardiovascular risk. NICE prioritises waist-to-height ratio alongside BMI for assessing cardiometabolic risk in adults.^[1][2]

Omron devices are best understood as consumer-grade monitoring tools that can support awareness and motivation. They are not diagnostic instruments, and their readings should not be used to make clinical decisions without professional input. If you are concerned about your visceral fat level, your GP is the appropriate first point of contact.

What can you do to lower a high visceral fat level?

Visceral fat responds well to aerobic exercise, reduced intake of ultra-processed foods and refined carbohydrates, increased dietary fibre, and improved sleep and stress management. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic activity per week.

A high Omron visceral fat reading can be reduced through sustained lifestyle changes, and evidence consistently shows that visceral fat responds well to the same interventions that improve overall cardiometabolic health. The most effective approach combines dietary change, increased physical activity and attention to sleep and stress.

Dietary changes that support visceral fat reduction include:

• Reducing intake of ultra-processed foods, refined carbohydrates and added sugars

• Increasing fibre from vegetables, legumes, wholegrains and fruit

• Choosing unsaturated fats over saturated fats

• Moderating alcohol intake, as alcohol consumption is associated with abdominal fat accumulation, in line with NHS guidance on alcohol and weight

Physical activity is particularly effective at reducing visceral fat, even before significant weight loss occurs. Both aerobic exercise (such as brisk walking, cycling or swimming) and resistance training contribute to visceral fat reduction. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults, alongside muscle-strengthening activities on two or more days.^[15][16]

Sleep and stress also play a meaningful role. Chronic sleep deprivation and elevated cortisol from ongoing stress both promote visceral fat accumulation, so addressing these factors supports the effectiveness of dietary and exercise changes.

For people with a BMI of 30 kg/m² or above, or 27.5 kg/m² or above in certain ethnic groups, clinically supervised weight management programmes may be appropriate. Access to specialist services and any pharmacological options depends on local Integrated Care Board (ICB) commissioning pathways and NICE technology appraisals, so availability varies. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of options may be considered if clinically appropriate following a consultation. If your visceral fat level remains high despite lifestyle changes, speak to your GP, who can assess your full cardiometabolic risk profile and advise on next steps.

Scientific References

1. Overweight and obesity management (NG246): Identifying and assessing overweight, obesity and central adiposity.
2. Overweight and obesity management (NG246).
3. Overweight and obesity in adults.
4. A simple cut-off for waist-to-height ratio (0·5) can act as an indicator of cardiometabolic risk.
5. The Impact of the Menopausal Transition on Body Composition.
6. Perimenopause and metabolic vulnerability: hormones, body composition and lifestyle changes. Climacteric.
7. Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan. Frontiers in Endocrinology.
8. Safety of Bioelectrical Impedance Analysis in Patients with Implanted Cardioverter-Defibrillators.
9. Bioimpedance analysis is safe in patients with implanted cardiac electronic devices.
10. AA in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Nonalcoholic Fatty Liver Disease (NAFLD). Reviews of Physiology, Biochemistry and Pharmacology.
11. Non-lean versus lean MASLD: associations with advanced cardiovascular-kidney-metabolic syndrome in adults with type 2 diabetes mellitus. Frontiers in Endocrinology.
12. The predictive value of a body shape index as a novel obesity metric for cancer risk: a systematic review and meta-analysis. Frontiers in Nutrition.
13. Association of computed tomography-derived body composition and complications after colorectal cancer surgery: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle.
14. Towards visceral fat estimation at population scale: correlation of visceral adipose tissue assessment using BIA, DXA, and single-slice CT. Frontiers in Endocrinology.
15. Physical activity guidelines: UK Chief Medical Officers' report.
16. UK Chief Medical Officers' physical activity guidelines (full guidance).
17. Physical activity guidelines for adults aged 19 to 64.
18. Aerobic Exercise and Weight Loss in Adults: A Systematic Review. JAMA Network Open.
19. Effects of concurrent training on fat mass and its distribution in individuals with overweight or obesity: a systematic review, meta-analysis, and exploratory regression analysis. BMC Public Health.
20. Exercise modalities for adults with type 2 diabetes mellitus and obesity: comparative effects on visceral fat, metabolism, and inflammatory markers from a network meta-analysis. Frontiers in Immunology.

Frequently Asked Questions